Capitol Health (CAJ.AX) Stock Price

Capitol Health Price

ASX·CLOSED
0.39
​
Market closed

Revenue has compounded at 48.1% per year over the past 18 years to 234.82 M AUD. Earnings per share have grown at 19.3% per year over the last 14 years. Capitol Health's net margin stands at -6.3%, down from 0.6% several years earlier. Capitol Health currently offers a dividend yield of about 3.33%. The dividend has grown at 7.0% per year over the past 12 years.

Capitol Health stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Capitol Health business model & stock analysis

Capitol Health Ltd operates diagnostic imaging clinics across Australia under brands including Capital Radiology, Imaging at Olympic Park, Radiology Tasmania, Fowler Simmons Radiology, Women’s Imaging, and Direct Radiology. The company generates revenue by providing diagnostic imaging services such as general X-rays, ultrasounds, CT scans, MRI, mammography, echocardiography, nuclear medicine, cardiac imaging, and musculoskeletal procedures to patients requiring these medical services. Its clinics, totaling approximately 63 locations in Victoria, Tasmania, Western Australia, and South Australia, serve patients seeking diagnostic imaging and interventional care. The firm focuses on delivering specialized medical imaging solutions through its established brand portfolio. The company’s revenue streams come from direct patient services at its clinics, with services categorized into general imaging, specialized procedures, and diagnostic modalities. Patients requiring medical imaging for diagnosis or treatment are the primary customers, utilizing the full range of services offered under Capitol Health’s brand names. The clinics operate in multiple Australian states, with a concentration in Victoria and Tasmania, serving both general and specialized healthcare needs. Capitol Health Ltd’s business model centers on providing comprehensive diagnostic imaging services through its network of clinics, with each location operating under distinct brand names to target specific patient segments. The company’s revenue is derived from the delivery of medical imaging services across various specialties, including radiology, women’s health, and musculoskeletal care, all managed under its operational structure. The firm’s service offerings are designed to meet the diagnostic needs of patients requiring interventional and specialized imaging procedures.

Frequently asked questions about Capitol Health

12 analysts currently rate the Capitol Health stock: 5 recommend buying, 7 holding and 0 selling. For 2026, analysts expect Capitol Health to generate revenue of 270.15 M AUD and earnings per share of 0.02 AUD.

Converted at the current exchange rate, the Capitol Health share trades at 0.24 EUR (0.39 AUD).

The Capitol Health share (CAJ.AX) is listed on 1 stock exchanges, including: ASX (CAJ.AX).

The expected revenue of Capitol Health is 270.15 M AUD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Capitol Health is 17.60 M AUD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Capitol Health is currently 23.26. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Capitol Health stock.

The price-to-sales ratio (P/S) of Capitol Health is currently 1.52. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Capitol Health stock.

The Eulerpool Quality Score for Capitol Health is 3/10.

The ISIN of Capitol Health is AU000000CAJ0. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Capitol Health is CAJ.AX. The ticker symbol is used to trade Capitol Health shares on the stock exchange.

Fair ValueTerminal
0.32 AUD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Providers & Services
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Australia
Currency
AUD
Initial public offering
Jun 9, 2006
ISIN
AU000000CAJ0
Cusip
Q20864106
Market capitalization
413.13 M AUDSmall Cap
52-Week Range
PEG
-1.94
P/E ratio
P/Ee 2025
28.84
P/Ee 2026
23.48
P/Ee 2027
19.35
P/S
P/Se
1.63
EV/EBIT
340.17
P/B Ratio
3.72
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-5.83 %
Dividend
Dividend yield
3.33 %
Est. Dividend Yield
3.02 %
Payout Ratio
-91.70 %
Dividend growth Ø5Y
-2.11 %
Dividend payments per year
2
Dividend paid since
0 years
Dividend not reduced since
0 years
Dividend increased since
0 years
Dividend withholding tax
30.00 %
Last updated Nov 15, 2026, 8:27 AM

Capitol Health Peer Group

Capitol Health Ticker

ASX · CAJ.AX

Capitol Health FIGI

CAJ:AU · BBG000PLHW88CAJ:AT · BBG000PLHWM2CAJ:AH · BBG002F3M7P5CAJEUR:X2 · BBG00HZRJ691CAJEUR:XB · BBG00HZRJ6B8CAJEUR:XH · BBG00HZRJ6D6CAJEUR:XF · BBG00HZRJ6G3CAJEUR:XE · BBG00HZRJ6J0CAJEUR:XJ · BBG00HZRJ6K8CAJEUR:XL · BBG00HZRJ6L7CAJEUR:XG · BBG00HZRJ6M6CAJEUR:XO · BBG00HZRJ6N5

All fundamentals and in-depth analysis of Capitol Health

Our stock analysis for Capitol Health stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Capitol Health. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.